His lab is focusing on refining the alanine-scanning assay to a few vital residues which can precisely distinguish between fibrils from neurodegenerative tauopathies. He envisions utilizing this streamlined assay for postmortem neuropathological prognosis, And maybe for blood screening of tauopathies.Similarly, in co-cultures of rat Principal cells